COVID-19 Rapid Review cross-publisher initiative: What we have learned and what we are going to do next

被引：8
|
作者：
Hurst, Phil [1 ]
Greaves, Sarah [2 ]
机构：
[1] Royal Soc, London, England
[2] STM Publishing Consultant, London, England
来源：
LEARNED PUBLISHING | 2021年 / 34卷 / 03期
关键词：
D O I：
10.1002/leap.1375
中图分类号：
G25 [图书馆学、图书馆事业]; G35 [情报学、情报工作];
学科分类号：
1205 ; 120501 ;
摘要：
The global crisis sparked collaboration between publishers and service providers to successfully address an immediate problem and demonstrated the possibility for future partnerships. Encouraging experts to join a reviewer pool and quickly review the preprint and journal submissions, we were able to publish COVID-19 research more quickly. The initiative confirmed little author uptake of inter-publisher journal transfer option. The collaboration showed wide consensus on open science practices which will ensure faster and more reliable research findings. © 2021 The Authors. Learned Publishing © 2021 ALPSP.
引用
收藏
页码：450 / 453
页数：4
相关论文
共 50 条
  • [31] School Asthma Care During COVID-19: What We Have Learned and What We Are Learning
    Abrams, Elissa M.
    Jordan, Kamyron
    Szefler, Stanley J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 453 - 459
  • [32] Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Jarrahi, Abbas
    Ahluwalia, Meenakshi
    Khodadadi, Hesam
    da Silva Lopes Salles, Evila
    Kolhe, Ravindra
    Hess, David C.
    Vale, Fernando
    Kumar, Manish
    Baban, Babak
    Vaibhav, Kumar
    Dhandapani, Krishnan M.
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [33] Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Abbas Jarrahi
    Meenakshi Ahluwalia
    Hesam Khodadadi
    Evila da Silva Lopes Salles
    Ravindra Kolhe
    David C. Hess
    Fernando Vale
    Manish Kumar
    Babak Baban
    Kumar Vaibhav
    Krishnan M. Dhandapani
    Journal of Neuroinflammation, 17
  • [34] Micronutrients in Sepsis and COVID-19: A Narrative Review on What We Have Learned and What We Want to Know in Future Trials
    Rossetti, Matteo
    Martucci, Gennaro
    Starchl, Christina
    Amrein, Karin
    MEDICINA-LITHUANIA, 2021, 57 (05):
  • [35] Vasculitis and COVID-19: what do we have to know?
    Tamburello, Antonio
    Castelno, Laura
    Bizzi, Emanuele
    Caso, Francesco
    ITALIAN JOURNAL OF MEDICINE, 2020, 14 (04) : 213 - 215
  • [36] Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
    Giannis, Dimitrios
    Douketis, James D.
    Spyropoulos, Alex C.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 96 : 13 - 16
  • [37] The role of vaccines in the COVID-19 pandemic: what have we learned?
    Krammer, Florian
    SEMINARS IN IMMUNOPATHOLOGY, 2024, 45 (4-6) : 451 - 468
  • [38] What have we learned in the 3 years of the COVID-19 pandemic?
    Maisch, Bernhard
    Doerr, Rolf
    HERZ, 2023, 48 (03) : 169 - 172
  • [39] Covid-19 deaths: what we have learned from the autopsy
    Sekhawat, Vivek
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S4 - S4
  • [40] Pediatric Trauma During COVID-19: What Have We Learned?
    Sudri, Shiran
    Shitrit, Shany
    Ben Amy, Dalit Porat
    Abu Dahoud, Wadie
    Laviv, Amir
    Abu El-Naaj, Imad
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2024, 82 (05) : 546 - 553
12345